InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Parsons James T., Director. Officer active across 2 companies, notably DiaMedica Therapeutics Inc.. Cumulatively, 6 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €9k. History available since 3 January 2022. The latest transaction was filed on 11 March 2026 (Acquisition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Parsons James T. is a Director at DiaMedica Therapeutics Inc. and ONCOLYTICS BIOTECH INC. He has 6 filings in total, and across the 6 recent filings tracked here, purchases total 8871 EUR with no sales, over the period from 2022-01-03 to 2026-03-13. The most common transaction nature is Attribution.